Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$67.81 USD

67.81
4,294,477

-0.25 (-0.37%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $67.84 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss

by Zacks Equity Research

Surmodics (SRDX) records higher revenues in its In Vitro Diagnostics core unit in the fiscal first quarter.

Zacks Equity Research

New Study Favors Myriad Genetics' (MYGN) GeneSight Test

by Zacks Equity Research

Myriad Genetics' (MYGN) GeneSight Psychotropic test is better for predicting patient outcomes and medication blood levels than single-gene testing, per new study.

Zacks Equity Research

Luminex (LMNX) Q4 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research

Luminex (LMNX) witnesses total sample-to-answer molecular diagnostics revenue growth in the fourth quarter.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for February 9th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 9th

Zacks Equity Research

Invest in Stocks With Momentum Anomaly for Higher Returns

by Zacks Equity Research

Skyworks (SWKS), Hologic (HOLX), II-VI (IIVI) and MaxLinear (MXL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Hologic (HOLX) is a Great Choice

by Zacks Equity Research

Does Hologic (HOLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Apple, FedEx, Ford, Hologic and Weyerhaeuser

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Apple, FedEx, Ford, Hologic and Weyerhaeuser

Zacks Equity Research

Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cardinal Health's (CAH) fiscal second-quarter results reflect strong segmental performance.

Nalak Das headshot

5 Top-Ranked Growth Stocks to Tap Market Rally in February

by Nalak Das

At this stage, it will be prudent to invest in growth stocks with a favorable Zacks Rank. These are: AAPl, F, FDX, HOLX, WY.

Nilanjan Choudhury headshot

5 Relative Price Strength Stocks That Investors Will Love

by Nilanjan Choudhury

DCP Midstream (DCP), TEGNA (TGNA), Hologic (HOLX), Crocs (CROX) and Skyworks Solutions (SWKS) are five stocks with explosive relative price strength.

Zacks Equity Research

Cardiovascular Systems (CSII) Posts Break-Even Earnings in Q2

by Zacks Equity Research

Cardiovascular Systems (CSII) registers dismal revenues despite gradual recovery in business amid the pandemic.

Zacks Equity Research

Align Technology (ALGN) Beats on Q4 Earnings, Margins Up

by Zacks Equity Research

Align Technology's (ALGN) segments report solid sales across geographies despite the pandemic-led business challenges.

Kevin Cook headshot

Biotech Bonanza: COVID Launches Science at Warp Speed

by Kevin Cook

From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.

Zacks Equity Research

STERIS' (STE) Earnings & Revenues Surpass Estimates in Q3

by Zacks Equity Research

STERIS' (STE) third-quarter fiscal 2021 results reflect strong performance by all three of its reporting segments despite the coronavirus-led economic crisis.

Zacks Equity Research

PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

PerkinElmer's (PKI) fourth-quarter results benefit from strong segmental performance.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for February 3rd

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 3rd

Panel Of Zacks Experts headshot

Top Stock Picks for Week of February 1, 2021

by Panel Of Zacks Experts

Solid Companies for Investors Interested in Medical Stocks and Big Boats.

Zacks Equity Research

IDEXX (IDXX) Earnings Beat Estimates in Q4, Margins Rise

by Zacks Equity Research

IDEXX (IDXX) registeres strong contribution from its CAG business in the fourth quarter despite pandemic-induced challenges.

Zacks Equity Research

McKesson (MCK) Earnings and Revenues Beat Estimates in Q3

by Zacks Equity Research

McKesson's (MCK) fiscal third-quarter 2021 results benefit from strong performance at Medical-Surgical Solutions segment.

Zacks Equity Research

Has Hologic (HOLX) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (HOLX) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Top Ranked Growth Stocks to Buy for February 1st

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 1st

Zacks Equity Research

NextGen Healthcare (NXGN) Loses 8.8% Despite Q3 Earnings Beat

by Zacks Equity Research

NextGen Healthcare's (NXGN) fiscal third-quarter earnings reflect strong segmental performance.

Zacks Equity Research

Accuray (ARAY) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Accuray (ARAY) registers growth in Service revenues during fiscal Q2.

Zacks Equity Research

3 Reasons Why Hologic (HOLX) Is a Great Growth Stock

by Zacks Equity Research

Hologic (HOLX) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Equity Research

ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q3

by Zacks Equity Research

ABIOMED's (ABMD) international Impella revenues improve in Q3.